Gene structure of the human receptor tyrosine kinase RON and mutation analysis in lung cancer samples

Genes Chromosomes and Cancer

Volumn 29, Issue 2, 2000, Pages 147-156

  Angeloni, Debora ^a   Danilkovitch Miagkova, Alla ^a   Ivanov, Sergey V ^b   Breathnach, Richard ^c   Johnson, Bruce E ^d   Leonard, Edward J ^a   Lerman, Michael I ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c INSTITUT DE BIOLOGIE   (France)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE;

ARTICLE; CANCER GROWTH; CARCINOGENESIS; CHROMOSOME 3P; DNA POLYMORPHISM; GENE MAPPING; GENE MUTATION; GENE STRUCTURE; HUMAN; HUMAN TISSUE; LUNG CANCER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 0033839793     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2264(2000)9999:9999<::AID-GCC1015>3.0.CO;2-N     Document Type: Article

References (40)

1. Andre C, Martin E, Cornu F, Hu WX, Wang XP, Galibert F. 1992. Genomic organization of the human c-kit gene: evolution of the receptor tyrosine kinase subclass III. Oncogene 7:685-691.
2. Bateman A, Birney E, Durbin R, Eddy SR, Finn RD, Sonnhammer ELL, 1999. Pfam 3.1: 1313 multiple alignments and profile HMMs match the majority of proteins. Nucleic Acids Res 27:260-262.
3. Bork P, Doerks T, Springer TA, Snel B. 1999. Domains in plexins: links to integrins and transcription factors. Trends Biochem Sci 24:261-263.
4. Brauch H, Johnson B, Hovis J, Yano T, Gazdar A, Pettengill OS, Graziano S, Sorenson GD, Poiesz BJ, Minna J, et al. 1987. Molecular analysis of the short arm of chromosome 3 in small-cell and non-small-cell carcinoma of the lung. N Engl J Med 317:1109-1113.
5. Burge C, Karlin S. 1997. Prediction of complete gene structures in human genomic DNA. J Mol Biol 268:78-94.
6. Collesi C, Santoro MM, Gaudino G, Comoglio PM. 1996. A splicing variant of the RON transcript induces constitutive tyrosine kinase activity and an invasive phenotype. Mol Cell Biol 16:5518-5526.
7. Dausset J, Cann H, Cohen D, Lathrop M, Lalouel JM, White R. 1990. Centre d'étude du polymorphisme humain (CEPH): collaborative genetic mapping of the human genome. Genomics 6:575-577.
8. Duh FM, Scherer SW, Tsui LC, Lerman MI, Zbar B, Schmidt L. 1997. Gene structure of the human MET proto-oncogene. Oncogene 15:1583-1586.
9. Gaudino G, Avantaggiato V, Follenzi A, Acampora D, Simeone A, Comoglio PM. 1995. The proto-oncogenc RON is involved in development of epithelial, bone and neuro-endocrine tissues. Oncogene 11:2627-2637.
10. Hewitt SM, Fraizer GC, Wu YJ, Rauscher 3rd FJ, Saunders GF. 1996. Differential function of Wilms tumor gene WT1 splice isoforms in transcriptional regulation. J Biol Chem 271:8588-8592.
11. Hirota S, Isozaki K, Monyama Y, Hashimoto K, Nishida T, Ishiguro S, Kawano K, Hanada M, Kurata A, Takeda M, Muhammad Tunio G, Matsuzawa Y, Kanakura Y, Shinomura Y, Kitamura Y. 1998. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279:577-580.
12. Hofstra RM, Landsvater RM, Ceccherini I, Stulp RP, Stelwagen T, Luo Y, Pasini B, Hoppener JW, van Amstel HK, Romeo G, et al. 1994. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 367:375-376.
13. Johnson BE, Makuch RW, Simmons AD, Gazdar AF, Burch D, Cashell AW. 1988. myc family DNA amplification in small cell lung cancer patients' tumors and corresponding cell lines. Cancer Res 48:5163-5166.
14. Kok K, Naylor SL, Buys CH. 1997. Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes. Adv Cancer Res 71:27-92.
15. Kolodkin AL, Matthes DJ, Goodman CS. 1993. The semaphorin genes encode a family of transmembrane and secreted growth cone guidance molecules. Cell 75:1389-1399.
16. Kwok JB, Gardner E, Warner JP, Ponder BA, Mulligan LM. 1993. Structural analysis of the human ret proto-oncogene using exon trapping. Oncogene 8:2575-2582.
17. Maestrini E, Tamagnone L, Longati P, Cremona O, Gulisano M, Bione S, Tamanini F, Neel BG, Toniolo D, Comoglio PM. 1996. A family of transmembrane proteins with homology to the MET-hepatocyte growth factor receptor. Proc Natl Acad Sci USA 23: 674-678.
18. Maggiora P, Marchio S, Stella MC, Giai M, Belfiore A, De Bortoli M, Di Renzo MF, Costantino A, Sismondi P, Comoglio PM. 1998. Overexpression of the RON gene in human breast carcinoma. Oncogene 16:2927-2933.
19. Medico E, Mongiovi AM, Huff J, Jelinek MA, Follenzi A, Gaudino G, Parsons JT, Comoglio PM. 1996. The tyrosine kinase receptors RON and SEA control "scattering" and morphogenesis of liver progenitor cells in vitro. Mol Biol Cell 7:495-504.
20. Mount S. 1982. A catalogue of splice junction sequences. Nucleic Acids Res 10:459-472.
21. Mulligan LM, Kwok JB, Healey CS, Elsdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, Papi L, et al. 1993. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363:458-460.
22. Nagata H, Worobec AS, Oh CK, Chowdhury BA, Tannenbaum S, Suzuki Y, Metcalfe DD. 1995. Identification of a point mutation in the catalytic domain of the proto-oncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematological disorder. Proc Natl Acad Sci USA 92:10560-10564.
23. Ohta K, Mizutani A, Kawakami A, Murakami Y, Kasuya Y, Takagi S, Tanaka H, Fujisawa H. 1995. Plexin: a novel neuronal cell surface molecule that mediates cell adhesion via a homophilic binding mechanism in the presence of calcium ions. Neuron 14:1189-1199.
24. Persons DA, Paulson RF, Loyd MR, Herley MT, Bodner SM, Bernstein A, Correll PH, Ney PA. 1999. Fv2 encodes a truncated form of the Stk receptor tyrosine kinase. Nat Genet 23:159-165.
25. Phelps RM, Johnson BE, Ihde DC, Gazdar AF, Carbone DP, Mc-Clintock PR, Linnoila RI, Matthews MJ, Bunn PA Jr, Carney D, Minna JD, Mulshine JL. 1996. NCI-Navy Medical Oncology Branch cell line data base. J Cell Biochem 24(Suppl):32-91.
26. Piao X, Bernstein A. 1996. A point mutation in the catalytic domain of c-kit induces growth factor independence, tumorigenicity, and differentiation of mast cells. Blood 87:3117-3123.
27. Ponzetto C, Bardelli A, Zhen Z, Maina F, dalla Zonca P, Giordano S, Graziani A, Panayotou G, Comoglio PM. 1994. A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family. Cell 77: 261-271.
28. Quantin B, Schuhbaur MC, Gesnel P, Dolle' P, Breatnach R. 1995. Restricted expression of the RON gene encoding the macrophage stimulating protein receptor during mouse development. Dev Dynamics 204:383-390.
29. Ronsin C, Muscatelli F, Mattei MG, Breathnach R. 1993. A novel putative receptor protein tyrosine kinase of the MET family. Oncogene 8:1195-1202.
30. Sambrook J, Fritsch EF, Maniatis T. 1989. Molecular cloning. A laboratory manual, 2nd edition. Cold Spring Harbor: Cold Spring Harbor Laboratory Press.
31. Santoto MM, Penengo L, Minrtto M, Orecchia S, Cilli M, Gaudino G. 1998. Point mutations in the tyrosine kinase domain release the oncogenic and metastatic potential of the RON receptor. Oncogene 17:741-749.
32. Schmidt L, Duh FM, Chen F, Kishida T, Glenn G, Choyke P, Scherer SW, Zhuang Z, Lubensky I, Dean M, Allikmets R, Chidambaram A, Bergerheim UR, Feltis JT, Casadevall C, Zamarron A, Bernues M, Richard S, Lips CJ, Walther MM, Tsui LC, Geil L, Orcutt ML, Stackhouse T, Zbar B, et al. 1997. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet 16:68-73.
33. Schmidt L, Junker K, Weirich G, Glenn G, Choyke P, Lubensky I, Zhuang Z, Jeffers M, Vande Woude G, Neumann H, Walther M, Linehan WM, Zbar B. 1998. Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene. Cancer Res 58:1719-1722.
34. Sharp PA. 1981. Speculations on RNA splicing. Cell 23:643-646.
35. Waltz SE, Toms CL, McDowell SA, Clay LA, Muraoka RS. Air EL, Sun WY, Thomas MB, Degen SJ. 1998. Characterization of the mouse RON/Stk receptor tyrosine kinase gene. Oncogene 16:27-42.
36. Wang M-H, Ronsin C, Gesnel MC, Coupey L, Skeel A, Leonard EJ, Breathnach R. 1994. Identification of the RON gene product as the receptor for the human macrophage stimulating protein. Science 266:117-120.
37. Wei MH, Latif F, Bader S, Kashuba V, Chen JY, Duh FM, Sekido Y, Lee CC, Geil L, Kuzmin I, Zabarovsky F, Klein G, Zbar B, Minna JD, Lerman MI. 1996. Construction of a 600-kilobase cosmid clone contig and generarion of a transcriptional map surrounding the lung cancer tumor suppressor gene (TSG) locus on human chromosome 3p21.3: progress toward the isolation of a lung cancer TSG. Cancer Res 56:1487-1492.
38. Zbar B, Lerman M. 1998. Inherited carcinomas of the kidney. Adv Cancer Res 75:163-201.
39. Zbar B, Brauch H, Talmadge C, Linehan M. 1987. Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma. Nature 327:721-724.
40. Zhen Z, Giordano S, Longati P, Medico E, Campiglio M, Comoglio PM. 1994. Structural and functional domains critical for constitutive activation of the HGF-receptor (MET). Oncogene 9:1691-1697.